All In MedTech

Device Trial Radar · NCT06675617

EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn

A Clinical Study to Evaluate the Effectiveness and Safety of the Allay® Aortic Stent as Adjunctive Endovascular Treatment of Type B Aortic Dissection in Patients Eligible for Thoracic Endovascular Repair With Stent Grafts

Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

72

Planned (sponsor's estimate)

Start

Oct 30, 2024

Primary completion

Jun 2027

Study completion Jun 2031

Sponsor

Lead sponsor
Intressa Vascular SANot on our public-company list
Sponsor type
Industry
First posted
Nov 5, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial is a prospective, multicenter, open label study designed to evaluate the effectiveness and the safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection in patients eligible for thoracic endovascular aortic repair with stent grafts.

Conditions

  • Type B Aortic Dissection

Interventions

  • Allay Aortic StentDevice

    Endovascular treatment of an aortic dissection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from aortic growth requiring secondary reintervention, including open conversion, or aortic rupture in the region treated by the Allay® Aortic Stent at 12 monthsTime frame: 12 months

Locations

21 sites in 8 countries. Site status is shown where the registry gives one.

  • Paracelsus Medical University Salzburg

    Salzburg, Austria · Not yet recruiting

  • Ziekenhuis Oost-Limburg

    Genk, Belgium · Recruiting

  • UZ Leuven

    Leuven, Belgium · Recruiting

18 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.